Navigation Links
Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008
Date:2/25/2009

- Exceeds 2008 Projections for Net Operating Income and Year-End Cash

- Achieves 2008 Positive Pro Forma Net Operating Income and Net Income

- Conference Call Webcast Wednesday, February 25, 8:30 a.m. EST at www.isispharm.com

CARLSBAD, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its 2008 financial results and business highlights. Isis exceeded its 2008 financial guidance by ending 2008 with positive pro forma net income of $3.1 million and positive pro forma net operating income of $226,000. The considerable improvement in Isis' financial results from 2007 was due to a significant increase in revenue that Isis generated in 2008 from its corporate partnerships. On a GAAP basis, Isis' loss from operations of $13.1 million and net loss of $12.0 million also improved significantly from its 2007 loss from operations and net loss. In addition to creating a continuing revenue base, Isis' corporate partnerships have considerably improved its cash position allowing Isis to finish 2008 with $491 million of cash, which does not include the $175 million that Isis received in January 2009 when it completed the sale of its Ibis Biosciences subsidiary to Abbott Molecular Inc (AMI).

"We believe that we are now at the beginning phase of sustained financial strength as evidenced by our 2008 financial results. With the sale of Ibis at the beginning of 2009, we started the year with more than $650 million in cash. In addition, we ended the year with positive pro forma net operating income and net income, further demonstrating our move toward continued financial strength. We expect to continue to benefit financially from the successful execution of our business strategy in 2009 and to move closer
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes
2. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
3. Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results
4. ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance
5. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
6. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
7. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
8. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
9. 1 in 10 Ex-NFL Players Used Steroids, Poll Reports
10. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
11. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Healthcare Solutions, the parent company of ... that it was honored to receive the Catamaran ... Conferred annually, the Innovation Award recognizes a client ... edge programs that improves cost and/or quality outcomes. ... its clinical and IT solutions that have helped ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The producers of ... May air dates for Peterborough, Ontario, Canada. The area is ... spot for Canadians and Americans. It is located an hour ... rivers. Peterborough is located in the Kawartha Hills, home to ... adds economic stability to the area. Residents and visitors to ...
(Date:5/21/2013)... 21, 2013 It’s nearly summer and millions ... or starting practice for summer or fall sports. In ... sporting activities can begin. , To help parents during ... youth sports or camp physicals at just $29. ... review a child’s medical history, perform a physical exam and ...
(Date:5/21/2013)... 21, 2013 Dallas-based TopMD™ Skin Care ... article testing the efficacy of their flagship product, ... clinical study results appear in the May/June 2013 issue ... “A Novel Sodium Hypochlorite Cleanser Shows Clinical Response and ... impressive findings seen after consistent use of the product ...
(Date:5/21/2013)... 2013 Dimensional Insight, a developer of ... Western Maryland Health System, a 275-bed hospital ... Solution™ (Diver) to help it analyze its data more ... to purchase Diver through Dimensional Insight’s recently announced ... hospitals, Western Maryland has massive amounts of data in ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3
... 3 Targeted Genetics Corporation,(Nasdaq: TGEN ) ... (NIH),Recombinant DNA Advisory Committee,s (RAC) assessment of the ... Phase I/II trial of,tgAAC94 for inflammatory arthritis., ... was a result of,complications from an opportunistic infection, ...
... ALBANY, N.Y., Dec. 3 AARP recently ... the state to,address three major issues that impact ... New Yorkers: prescription drug marketing reform and,affordability, housing ... are critical issues that help New Yorkers stay ...
... Dec. 3 Coherent, Inc.,(Nasdaq: COHR ) today ... of the Board of Directors of The Nasdaq Stock ... file its past due periodic reports,for the year ended ... 2007 with the Securities Exchange Commission ("SEC") in order ...
... ORLANDO, Fla., Dec. 3 A new study ... depressant effects in,patients (40 years and older) with ... measured by oxygenation or abnormal breathing,events relative to ... at the 53rd International,Respiratory Congress of the American ...
... that protect cells from the powerful, common chemotherapeutic agent ... how the drug also can destroy the heart., We ... for cell survival in the face of doxorubicin, says ... of Georgia Cancer Center. At the moment you start ...
... to lead can hinder the brains ability to recover ... The results have implications for the effects of environmental ... researchers at Jefferson Medical College, who led the work. ... increase the risk for cancer, renal disease, hypertension and ...
Cached Medicine News:Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 2Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 3Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 4Health News:AARP Urges Governor to Use Budget to Improve New Yorkers' Quality of Life 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 2Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 4Health News:Genes identified that protect against heart damage from chemotherapy 2Health News:Jefferson neuroscientists find early lead exposure impedes recovery from brain injury 2
(Date:5/20/2013)... , May 20, 2013  B. Braun ... clinician and environmental safety with products, services and ... will feature its innovative Outlook® 400ES and Space ... barcoding capabilities at the American Association of Critical-Care ... the Boston Convention Center. ...
(Date:5/20/2013)... Mass. , May 20, 2013 ... ("OSI")  whose subsidiary companies include OMNIlife science®, Inc., Enztec, ... directors to their Board.  Guy Mayer ... as the Chairman of the Board of Directors ... join as a director. Before joining ...
(Date:5/20/2013)... ALEXANDRIA, Va. , May 20, 2013   ... B. Douglas Hoey , RPh, MBA issued the ... Hart Research Associates regarding Medicare Part D "preferred ... pharmacies from offering patients the plan,s lowest advertised co-payments: ... "Officials with Medicare and MedPAC , ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... Inc. (NYSE: HRC ) will release its fiscal ... company will host a webcast the following morning on Thursday, ... Earnings Release:   Hill-Rom,s Fiscal 2011 Third Quarter Earnings Release ... to the public after the close of the NYSE on ...
... N.J., June 29, 2011 Par Pharmaceutical Companies, Inc. ... of its branded division, Strativa Pharmaceuticals, as part of ... a workforce reduction of approximately 100.  The Company believes ... the near term. Patrick G. LePore, Chairman, ...
Cached Medicine Technology:Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast 2Par Pharmaceutical Companies Announces a Restructuring of Its Branded Division, Strativa Pharmaceuticals, to Maximize Profitability 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: